Home About us Contact
|
Home About us Contact | ||
|
|
||
Wistar Strain (wistar + strain)
Selected AbstractsAntihyperlipidemic activity of 3-hydroxymethyl xylitol, a novel antidiabetic compound isolated from Casearia esculenta (Roxb.) root, in streptozotocin-diabetic ratsJOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, Issue 2 2010Govindasamy Chandramohan Abstract Casearia esculenta root (Roxb.) is widely used in traditional system of medicine to treat diabetes in India. An active compound, 3-hydroxymethyl xylitol (3-HMX), has been isolated, and its optimum dose has been determined in a short duration study and patented. In addition, the long-term effect of 3-HMX in type 2 diabetic rats on carbohydrate metabolism was investigated, and its antihyperglycemic effect was shown previously (Chandramohan et al., Eur J Pharmacol 2008;590:437,443). In this study we investigated the effect of 3-HMX on plasma and tissue lipid profiles in streptozotocin-induced diabetic rats. Diabetes was induced in adult male albino rats of the Wistar strain, weighing 180,200 g, by administration of streptozotocin (40 mg/kg of body weight) intraperitoneally. The normal and diabetic rats were treated with 3-HMX (40 mg/kg BW/day) for 45 days. The levels of total cholesterol, triglycerides, free fatty acids, and phospholipids were assayed in the plasma besides lipoprotein-cholesterol (high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), and very low density lipoprotein-cholesterol (VLDL-C)) and tissues (liver, kidney, heart, and brain). Total cholesterol, triglyceride, free fatty acid, and phospholipid (LDL-C and VLDL-C in plasma only) levels increased in plasma and tissues significantly, whereas plasma HDL-C significantly decreased in diabetic rats. Treatment with 3-HMX or glibenclamide reversed the above-mentioned changes and improved toward normalcy. Histological study of liver also confirmed the biochemical findings. Thus administration of 3-HMX is able to reduce hyperglycemia and hyperlipidemia related to the risk of diabetes mellitus. © 2010 Wiley Periodicals, Inc. J Biochem Mol Toxicol 24:95,101, 2010; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.20317 [source] Osteogenesis by guided tissue regeneration and demineralized bone matrixJOURNAL OF CLINICAL PERIODONTOLOGY, Issue 3 2003N. Mardas Abstract Aim:, To evaluate in a discriminating capsule model whether bone formation by guided tissue regeneration (GTR) may be influenced by concomitant implantation of demineralized bone matrix (DBM). Materials and Methods:, Thirty 4-month-old male albino rats of the Wistar strain were used in the study. Following surgical exposure of the mandibular ramus, a hemispherical, Teflon capsule (5.0 mm in diameter), loosely packed with a standardized amount of DBM, was placed with its open part facing the lateral bone surface of the ramus. At the contralateral side, an empty capsule was placed, serving as control. After healing periods of 15, 30, and 120 days, groups of 10 animals were sacrificed and 40,70 ,m thick undecalcified sections of the capsules were produced. In the sections, the cross-sectional areas of (1) the space created by the capsule, (2) newly formed bone, (3) DBM particles, (4) loose connective tissue as well as the (5) height of the capsules, and (6) that of the newly formed bone were measured. Results:, Increasing bone fill was observed in both test and control sites from 30 to 120 days. After 30 days of healing, the mean amount of bone was approx. 3% of the cross-sectional area of the capsules at the test sites while it was 8% in the control sites (p<0.05). However, no statistically significant differences were observed between the test (46%) and control (64%) sites after 120 days regarding any of the measured parameters (p>0.05). The newly formed bone in the DBM group at 120 days, on the other hand, appeared more dense than that in the control capsules. Conclusion:, DBM used as an adjunct to GTR did not provide any added effect on bone formation but increased the density of the newly formed bone. Zusammenfassung Ziel: Die Untersuchung in einem Kapselmodell, welches differenzieren kann, ob die Knochenbildung durch GTR durch die gleichzeitige Implantation von demineralisierter Knochenmatrix (DBM) beeinflusst werden könnte Material und Methoden: Dreißig männliche 4-Monate-alte Albinoratten des Wistar Stammes wurden in der Studie verwendet. Nach der chirurgischen Freilegung des Unterkieferastes wurde eine halbkugelförmige Teflonkapsel (5,0 mm Durchmesser), welche locker mit einer standardisierten Menge von DBM versehen war, wurde mit ihrer offenen Fläche auf die seitlichen Knochenfläche des Ramus gelegt. Auf der kontralateralen Seite diente eine leere Kapsel als Kontrolle. Nach Heilungsintervallen von 15, 30 und 120 Tagen wurden Gruppen von 10 Tieren geopfert und 40-70 ,m dicke nicht-entkalkte Schnitte der Kapseln wurden hergestellt. An den Schnitten wurde die Querschnittsfläche von: 1) der Fläche, die von der Kapsel geschaffen wurde, 2) dem neu gebildeten Knochen, 3) den DBM-Partikeln, 4) dem lockeren Bindegewebe gemessen, als auch 5) die Höhe der Kapseln und 6) des neu gebildeten Knochens bestimmt. Ergebnisse: Von Tag 30 zu Tag 120 wurde sowohl bei den Test- als auch bei den Kontrollstellen eine erhöhte Knochenauffüllung beobachtet. Nach 30 Tagen der Heilung betrug an den Teststellen die mittlere Knochenmenge ungefähr 3% der Querschnittsfläche der Kapseln, während sie an den Kontrollstellen 8% (p<0,05) betrug. Jedoch wurde nach 120 Tagen bei keinem der gemessenen Parameter eine statistisch signifikante Differenz zwischen den Test- (46%) und den Kontrollstellen (64%) beobachtet. Auf der anderen Seite erschien nach 120 Tagen in der DBM-Gruppe der neu gebildete Knochen dichter als in den Kontrollkapseln Schlussfolgerung: DBM welches als Zusatz bei der GTR verwendet wurde, lieferte keinen zusätzlichen Effekt bei der Knochenbildung, aber erhöhte die Dichte des neu gebildeten Knochens. Résumé Le but de cette étude a été d'évaluer dans un modèle de capsule discriminatoire si la formation osseuse par regénération tissulaire guidée (GTR) pouvait être influencée par l'implantation concomitante de matrice osseuse déminéralisée (DBM). Trente rats albinos mâles âgés de quatre mois de la souche Wistar ont été utilisés pour cette étude. A la suite de l'exposition chirurgicale de la branche montante mandibulaire, une capsule en téflon hémisphérique de 0,5 mm de diamètre remplie sans tassement avec une quantité standardisée de DBM a été placée avec sa partie ouverte contre la surface osseuse latérale de la branche. Du côté contralatéral, une capsule vide était placée servant de contrôle. Après des périodes de guérison de 15, 30 et 120 jours, des groupes de dix animaux ont été tués et des coupes non-décalcifiées de 40 à 70 ,m d'épaisseur des capsules ont été effectuées. Dans ces coupes, une aire sur coupe transversale contenant 1) l'espace créé par la capsule, 2) l'os néoformé, 3) des particules DBM, 4) du tissu conjonctif lâche; 5) la hauteur des capsules et 6) et celle de l'os néoformé ont été mesurés. Un comblement osseux de plus en plus important tant dans les sites contrôles que les sites tests a été constaté entre les jours 30 et 120. Après 30 jours de guérison, la quantité moyenne d'os formait approximativement 3% de l'aire de la coupe des capsules dans les sites tests tandis qu'elle était de 8% dans les sites contrôles (p<0,05). Cependant, aucune différence statistique n'a été observée entre les sites tests (46%) et les sites contrôles (64%) après 120 jours pour les paramètres mesurés (p>0,05). L'os néoformé dans le groupe DBM à 120 jours semblait plus dense que dans les capsules contrôles. Le DBM utilisé durant la GTR n'apportait aucun effet additionnel sur la formation osseuse mais augmentait cependant la densité du nouvel os formé. [source] Ultrastructural Features of Myenteric Ganglia of Adult Wistar Rats (Rattus norvegicus)ANATOMIA, HISTOLOGIA, EMBRYOLOGIA, Issue 6 2000M. R. M. Natali Summary The ultrastructural features of the ganglia of the myenteric plexus exhibit changes according to the animal species. These myenteric ganglia in the duodenum of adult rats of the Wistar strain were characterized ultrastructurally in this work. Those ganglia were depicted as compact structures, composed of neurones and glial cells, forming a dense neuropil surrounded by a continuous basal lamina and collagen fibrils. Glial cell bodies were smaller and apparently more frequent than neuronal cell bodies, being morphologically distinguished by nuclear features. In the neuronal extensions granular and agranular synaptic vesicles of different sizes predominate, in addition to mitochondria and myelinized profiles. Gliofilaments were not observed on the glial extensions of the rats. [source] Sulphated Polysaccharides: New Insight in the Prevention of Cyclosporine A-Induced Glomerular InjuryBASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY, Issue 1 2007Anthony Josephine Nephrotoxicity induced by cyclosporine A continues to be a major problem despite its potent immunosuppressive action. Adult male albino rats of Wistar strain were categorized into four groups. Two groups (II and IV) were administered cyclosporine A (25 mg/kg body weight, orally) for 21 days, in which Group IV rats were also treated simultaneously with sulphated polysaccharides (5 mg/kg body weight, subcutaneously) for the same period. A significant loss in body weight was noted in the cyclosporine A-induced rats. Renal damage was assessed in terms of decreased creatinine clearance and increased activity of lysosomal enzymes. The levels of glycoproteins were found to be decreased in the renal tissue, and a noticeable rise in glycosaminoglycanuria coupled with marked proteinuria was more prominent in the cyclosporine A-induced animals. Furthermore, the extent of kidney damage was assessed by histopathological findings. Toxic manifestations were also confirmed by transmission electron microscopic studies. These morphological abnormalities and other alterations in the renal tissue were significantly offset by sulphated polysaccharides supplementation. These findings underline that restoration of normal cells accredits sulphated polysaccharides, from Sargassum wightii, with nephroprotective role, against cyclosporine A-induced renal injury. [source] Mutations and Reduced Expression of the Transforming Growth Factor-, Receptor II Gene in Rat Lung Adenocarcinomas Induced by N -Nitrosobis-(2-hydroxypropyl)amineCANCER SCIENCE, Issue 11 2000Toshifumi Tsujiuchi Mutations and expression of the transforming growth factor-, receptor type II (TGF-,RII) gene were investigated in lung adenocarcinomas induced by N -nitrosobis(2-hydroxypropyl)amine (BHP) in rats. Males of the Wistar strain, 6 weeks old, were given 2000 ppm of BHP in their drinking water for 12 weeks and then maintained without further treatment until killed at week 25. Total RNA was extracted from 12 adenocarcinomas and mutations in TGF-,RII were investigated by RT-PCR-restriction-SSCP analysis followed by sequencing analysis. Two out of 12 adenocarcinomas showed band shifts, indicative of mutations (16.7%). One was a CTG-to-TTG (Leu to Leu) transition at codon 308 without amino acid alteration and the other a frameshift deletion of one of two guanines at nucleotides 1434 to 1435 (codon 477 to 478). Semi-quantitative RT-PCR analysis demonstrated significantly reduced TGF-,RII expression in adenocarcinomas, as compared with normal lung tissue. These results suggest that TGF-,RII alterations may play a role in the acquisition of growth advantage by lung adenocarcinomas induced by BHP in rats. [source] Dose- and Sex-related Carcinogenesis by N-Bis(2-hydroxypropyl)nitrosamine in Wistar RatsCANCER SCIENCE, Issue 4 2000Eduardo L. T. Moreira An initiation-promotion medium-term bioassay for detection of chemical carcinogens, developed in the male F344 rat, uses 0.1% N-bis(2-hydroxypropyl)nitrosamine (DHPN) among five genotoxic chemicals for the initiation of carcinogenesis in multiple organs. To establish this bioassay in the Wistar strain, the effects of two dose levels of DHPN were evaluated on the main DHPN rat target organs: lung, thyroid gland, kidneys and liver. Four groups of male and female animals were studied: Control,untreated group; Multi-organ initiated group (also referred to as DMBDD, based on the initials of the five initiators),treated sequentially with N-diethylnitrosamine (DEN, i.p.), N-methyl-N-nitrosourea (MNU, i.p.), N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN, drinking water), N, ,N,-dimethylhydrazine (DMH, s.c.) and DHPN (drinking water) for 4 weeks; a third group treated with 0.1% DHPN in drinking water for 2 weeks and the last group treated with 0.2% DHPN in drinking water for 4 weeks. The animals were sacrificed after 30 weeks. DHPN at 0.2% induced preneoplasia in the liver and kidneys of rats of both sexes, the number and area of the putative preneoplastic liver glutathione S-transferase-positive hepatocyte foci being significantly increased in these animals. It also induced benign and malignant tumors in female and in male rats. However, there was no relationship between the increased incidence of preneoplastic lesions and tumor development in the 0.2% DHPN-exposed groups of both sexes. DHPN at 0.1% induced only a few preneoplastic lesions in the liver and kidney and no tumors in both male and female rats. A clear dose and sex-related carcinogenic activity of DHPN was registered, although Wistar rats of both sexes showed a relative resistance to the carcinogenic activity of this compound. [source] | ||||||||||